An '''orexigenic''', or '''appetite stimulant''', is a [[drug]], [[hormone]], or [[chemical compound|compound]] that increases [[appetite]]. This can be a naturally occurring [[neuropeptide]] hormone such as [[ghrelin]], [[orexin]] or [[neuropeptide Y]],<ref>Diepvens K, Häberer D, Westerterp-Plantenga M. Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans.Int J Obes (Lond). 2008 Mar;32(3):510-8. Epub 2007 Nov 27.PMID 18345020</ref><ref name="pmid20590826">{{cite journal |author=Akimoto S, Miyasaka K |title=Age-associated changes of hunger-regulating peptides |journal=Geriatrics & Gerontology International |volume=10 Suppl 1 |issue= |pages=S107–19 |year=2010 |month=July |pmid=20590826 |doi=10.1111/j.1447-0594.2010.00587.x |url=}}</ref> or a [[medication]] which increases hunger and therefore enhances [[food consumption]]. Usually appetite enhancement is considered an undesirable [[side effect]] of certain [[drug]]s as it leads to unwanted [[weight gain]],<ref name="pmid15871553">{{cite journal |author=Purnell JQ, Weyer C |title=Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity |journal=Treatments in Endocrinology |volume=2 |issue=1 |pages=33–47 |year=2003 |pmid=15871553 |doi= |url=}}</ref><ref name="pmid18035865">{{cite journal |author=Hermansen K, Mortensen LS |title=Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus |journal=Drug Safety : an International Journal of Medical Toxicology and Drug Experience |volume=30 |issue=12 |pages=1127–42 |year=2007 |pmid=18035865 |doi= |url=}}</ref><ref name="pmid20586697">{{cite journal |author=Maayan L, Correll CU |title=Management of antipsychotic-related weight gain |journal=Expert Review of Neurotherapeutics |volume=10 |issue=7 |pages=1175–200 |year=2010 |month=July |pmid=20586697 |doi=10.1586/ern.10.85 |url=}}</ref> but sometimes it can be beneficial and a drug may be prescribed solely for this purpose, especially when the patient is suffering from severe appetite loss or muscle wasting due to [[cystic fibrosis]], [[Anorexia (symptom)|anorexia]], [[old age]], [[cancer]] or [[AIDS]].<ref name="pmid12170570">{{cite journal |author=Strasser F, Bruera ED |title=Update on anorexia and cachexia |journal=Hematology/oncology Clinics of North America |volume=16 |issue=3 |pages=589–617 |year=2002 |month=June |pmid=12170570 |doi= |url=}}</ref><ref name="pmid18219690">{{cite journal |author=Nasr SZ, Drury D |title=use in cystic fibrosis |journal=Pediatric Pulmonology |volume=43 |issue=3 |pages=209–19 |year=2008 |month=March |pmid=18219690 |doi=10.1002/ppul.20766 |url=}}</ref><ref name="pmid18220800">{{cite journal |author=Morley JE |title=Weight loss in older persons: new therapeutic approaches |journal=Current Pharmaceutical Design |volume=13 |issue=35 |pages=3637–47 |year=2007 |pmid=18220800 |doi= |url=}}</ref><ref name="pmid19323618">{{cite journal |author=Fox CB, Treadway AK, Blaszczyk AT, Sleeper RB |title=Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly |journal=Pharmacotherapy |volume=29 |issue=4 |pages=383–97 |year=2009 |month=April |pmid=19323618 |doi=10.1592/phco.29.4.383 |url=}}</ref><ref name="pmid19648846">{{cite journal |author=Holmes S |title=A difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care |journal=International Journal of Palliative Nursing |volume=15 |issue=7 |pages=320, 322–6 |year=2009 |month=July |pmid=19648846 |doi= |url=}}</ref> There are several widely used drugs which can cause a boost in appetite, including [[tricyclic antidepressant]]s (TCAs), [[tetracyclic antidepressant]]s, natural or synthetic [[cannabinoid]]s, first-generation [[antihistamine]]s, most [[antipsychotic]]s and many [[steroid hormone]]s.

Agents with orexigenic effects include the following:

* [[5-HT2C receptor|5-HT<sub>2C</sub> receptor]] [[receptor antagonist|antagonist]]s/[[inverse agonist]]s – [[mirtazapine]], [[olanzapine]], [[quetiapine]], [[amitriptyline]],  [[cyproheptadine]]
* [[Histamine H1 receptor|H<sub>1</sub> receptor]] [[receptor antagonist|antagonist]]s/[[inverse agonist]]s – [[mirtazapine]], [[olanzapine]], [[quetiapine]], [[amitriptyline]], [[cyproheptadine]]
* [[Dopamine antagonist]]s – [[haloperidol]], [[chlorpromazine]], [[olanzapine]], [[risperidone]], [[quetiapine]]
* [[Adrenergic antagonist]]s – [[carvedilol]], [[propranolol]]; [[Alpha-adrenergic_agonist#α2-adrenergic agonists|α<sub>2</sub>-adrenergic agonists]] – [[clonidine]]
* [[CB1 receptor|CB<sub>1</sub> receptor]] [[agonist]]s ([[cannabinoid]]s – [[tetrahydrocannabinol|THC/dronabinol]] (a component of ''[[Cannabis]]''), [[nabilone]]
* [[Corticosteroid]]s – [[dexamethasone]], [[prednisone]], [[hydrocortisone]]
* Certain [[pregnene]] [[steroid]]s – [[megestrol acetate]], [[medroxyprogesterone acetate]]
* [[Anabolic steroid]]s – [[oxandrolone]], [[nandrolone]], [[testosterone]]
* [[Sulfonylurea]] antidiabetic drugs – [[glibenclamide]] and [[chlorpropamide]]

== See also ==
* [[Anorectic]]
* [[Anorexia (symptom)|Anorexia]]
* [[Eating disorder]]
* [[Obesity]]
* [[Organic feeding disorder]]
* [[Polydipsia]]
* [[Polyphagia]] (or [[hyperphagia]])

== References ==
{{Reflist}}


{{General symptoms and signs}}
{{Orexigenics}}

[[Category:Drugs]]


{{health-stub}}
{{biology-stub}}